Currently out of the existing stock ratings of Anthony Petrone, 352 are a BUY (81.48%), 77 are a HOLD (17.82%), 3 are a SELL (0.69%).

Anthony Petrone

Work Performance Price Targets & Ratings Chart

Analyst Anthony Petrone, currently employed at MIZUHO, carries an average stock price target met ratio of 63.8% that have a potential upside of 32.77% achieved within 294 days.

Anthony Petrone’s has documented 861 price targets and ratings displayed on 40 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ISRG, Intuitive Surgical at 21-Oct-2026.

Wall Street Analyst Anthony Petrone

Analyst best performing recommendations are on VRAY (VIEWRAY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 6/15/2020. The price target of $55 was fulfilled within 7 days with a profit of $9.77 (21.6%) receiving and performance score of 30.86.

Average potential price target upside

of $36.84 (27.13%) on INSP (INSPIRE MEDICAL SYSTEMS).
of $34.05 (80.16%) on LIVN (LIVANOVA PLC).
of $25.84 (23.45%) on ZBH (ZIMMER BIOMET HOLDINGS).

ATRS Antares Pharma COO The Cooper Companies EW Edwards Lifesciences Corp HAE Haemonetics MNK Mallinckrodt plc RMD ResMed TARS Tarsus Pharmaceuticals VAR Varian Medical Systems VREX Varex Imaging Corp ALC Alcon AG GKOS Glaukos Corp HOLX Hologic LMAT LeMaitre Vascular LNTH Lantheus Holdings ZBH Zimmer Biomet Holdings LIVN LivaNova PLC ABMD ABIOMED ABT Abbott Laboratories ADMA ADMA Biologics ESTA Establishment Labs Holdings MDT Medtronic PLC STAA STAAR Surgical Company ISRG Intuitive Surgical INSP Inspire Medical Systems NVRO Nevro Corp TFX Teleflex VRAY ViewRay MDXG MiMedx Group AXNX Axonics Modulation Technologies BSX Boston Scientific Corp GEHC GE HealthCare Technologies DXCM DexCom EMBC Embecta Corp GH Guardant Health EXAS EXACT Sciences MNKD MannKind Corp SENS Senseonics Holdings TNDM Tandem Diabetes Care AG First Majestic Silver Corp AXGN Axogen

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Elliot Wilbur

Hold Since 14-Apr-2022

$0.41 (7.33%)

4 years 6 months 26 days ago
(14-Apr-2022)

0/3 (0%)

$0.44 (7.91%)

Please subscribe to see extended stock data

David Amsellem (PIPER SANDLER)

Buy Since 23-Oct-2017

$5.6

$0.01 (0.18%)

4 years 6 months 26 days ago
(14-Apr-2022)

1/3 (33.33%)

$0.04 (0.72%)

294

Please subscribe to see extended stock data

Oren Livnat (HC WAINWRIGHT)

Buy Since 08-Oct-2013

4 years 6 months 26 days ago
(14-Apr-2022)

11/12 (91.67%)

$1.22 (32.28%)

380

Please subscribe to see extended stock data

Gregg Gilbert (BAML)

Hold Since 13-Apr-2022

4 years 6 months 28 days ago
(13-Apr-2022)

0/1 (0%)

$2.85 (68.67%)

Please subscribe to see extended stock data

Anthony Petrone (MIZUHO)

Buy Since 09-Mar-2016

$2.41 (43.11%)

8 years 3 days ago
(06-Nov-2018)

1/3 (33.33%)

$4.39 (121.61%)

412

Please subscribe to see extended stock data

Show more analysts

Please expand the browser size to see the chart

Which stock is Anthony Petrone most bullish on?

Potential upside of $49.13 has been obtained for GH (GUARDANT HEALTH)

Which stock is Anthony Petrone most reserved on?

Potential downside of -$52.8 has been obtained for ISRG (INTUITIVE SURGICAL)

What Year was the first public recommendation made by Anthony Petrone?

On 2010